Picture of Pro Medicus logo

PME — Pro Medicus Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Momentum

Relative Strength (%)
1m-13.27%
3m-2.94%
6m-29.75%
1yr-3.28%
Volume Change (%)
10d/3m+3.61%
Price vs... (%)
52w High-40.66%
50d MA-9.37%
200d MA-21.14%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)78.83
PEG Ratio (f)3.47
EPS Growth (f)29.41%
Dividend Yield (f)0.64%
Valuation (ttm)IndustryMarket
Price to Book Value45.55
Price to Tang. Book58.55
Price to Free Cashflow105.26
Price to Sales53.51
EV to EBITDA71.32

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital44.29%
Return on Equity45.77%
Operating Margin66.7%

Financial Summary

Year End 30th JunUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueAU$m31.6233.9350.3556.9968.0692.79116.0319.8%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+42.53+6.74+91.67+20.62+33.52+42.74+28.27n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for PME

Does Pro Medicus (ASX:PME) have an economic moat? background image

Does Pro Medicus (ASX:PME) have an economic moat?

The persistent risk of economic uncertainty and market volatility mean that it can be worth seeking out high quality stocks for your portfolio. Safe, profitable companies with strong balance sheets can offer solid returns over the long...

Where next for the Pro Medicus share price? background image

Where next for the Pro Medicus share price?

Shares in Pro Medicus (ASX:PME) are currently trading at 46.77 but a key question for investors is how the economic uncertainty might affect the price in the months to come. The answer comes down to judging whether Pro Medicus is well...

Two factors that could move the Pro Medicus (ASX:PME) share price background image

Two factors that could move the Pro Medicus (ASX:PME) share price

The Pro Medicus (ASX:PME) share price is currently trading at 45.65. But given the uncertain economic outlook, the question now is what the future holds for it... To try and predict where the Pro Medicus price will head next, it's wort...

Four clues to the quality of Pro Medicus (ASX:PME) background image

Four clues to the quality of Pro Medicus (ASX:PME)

Warren Buffett makes it look so easy: find high-quality companies, wait for a fair price to buy, and then hold them... forever. The problem of course is that these stocks are hard to find - but there are signs that Pro Medicus ASX:PME...

Four clues to the quality of Pro Medicus (ASX:PME) background image

Four clues to the quality of Pro Medicus (ASX:PME)

Warren Buffett makes it look so easy: find high-quality companies, wait for a fair price to buy, and then hold them... forever. The problem of course is that these stocks are hard to find - but there are signs that Pro Medicus ASX:PME...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202230th Jun 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Pro Medicus EPS forecast chart

Profile Summary

Pro Medicus Limited is an Australia-based healthcare informatics company. The Company is a developer and supplier of healthcare imaging software and services to hospitals, diagnostic imaging groups and other related health entities in Australia, North America and Europe. The Company's products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a Radiology Information Systems (RIS) medical software for practicing of management, training, installation and professional services. Visage RIS capabilities include patient registration; billing; scheduling; typing; HL7 integration; financial reporting; digital dictation and voice recognition integration. Its Visage 7.0 is a healthcare imaging software that provides radiologists and clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images and picture archive and communication system (PACS)/digital imaging software.

Directors

Last Annual
June 30th, 2021
Last Interim
December 31st, 2021
Incorporated
September 7th, 1983
Public Since
October 10th, 2000
No. of Shareholders
11,026
No. of Employees
79
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
104,386,313

PME Share Price Performance

Upcoming Events for PME

Full Year 2022 Pro Medicus Ltd Earnings Release

Similar to PME

Picture of 4DMedical logo

4DMedical

au flag iconAustralian Stock Exchange - SEATS

Picture of Adherium logo

Adherium

au flag iconAustralian Stock Exchange - SEATS

Picture of Allegra Orthopaedics logo

Allegra Orthopaedics

au flag iconAustralian Stock Exchange - SEATS

Picture of Analytica logo

Analytica

au flag iconAustralian Stock Exchange - SEATS

Picture of Ansell logo

Ansell

au flag iconAustralian Stock Exchange - SEATS

FAQ

Or unlock with your email

Or unlock with your email